BBIO BridgeBio Pharma, Inc. - Common Stock
$84.70
价格 · 八月 19, 2026
截至...的财报数据 八月 10, 2026
52周区间
$47–$93
81% of range
分析师评级
BUY
28 analysts
目标价
$108
+28% upside
P/E (TTM)
-22.5
ROE
41.2%
净利润率
-146.0%
BBIO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$84.70
市值
$16.58B
P/E (TTM)
-22.5
每股收益 (TTM)
$-3.78
营收 (TTM)
$502M
股息收益率
—
ROE
41.2%
负债/权益
—
52周区间
$47 – $93
BBIO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$502M
2019-12-31
→
2025-12-31
EPS
$-3.78
2020-12-31
→
2025-12-31
自由现金流
$-447M
2019-12-31
→
2025-12-31
利润率
-146.0%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
BBIO
同行中位数
P/E (TTM)
-22.5
28.5
P/S (TTM) (市销率 (TTM))
33.0
20.1
P/B (市净率)
-7.9
12.9
Price / FCF (股价/自由现金流)
-37.1
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
BBIO
同行中位数
Operating Margin (营业利润率)
-104.2%
—
Net Profit Margin (净利润率)
-146.0%
-48.4%
ROA
-79.0%
-28.4%
ROE
41.2%
-49.2%
ROIC
25.1%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
BBIO
同行中位数
Current Ratio (流动比率)
2.8
5.0
Quick Ratio (速动比率)
2.5
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
BBIO
同行中位数
Revenue YoY (营收同比增长)
126.3%
—
Revenue CAGR 3Y (营收3年复合年增长率)
86.3%
—
Revenue CAGR 5Y (营收5年复合年增长率)
127.4%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
BBIO
同行中位数
BBIO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
28 位分析师
- 强烈买入 6 21.4%
- 买入 19 67.9%
- 持有 3 10.7%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
21 位分析师 · 2026-08-16
中位数
$108.00
现在
$84.70
最低
$80.00
最高
$157.00
中位数目标
$108.00
+27.5%
平均目标
$108.43
+28.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.11%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.78 | $-0.60 | -0.18% |
| 2026年3月31日 | $-0.84 | $-0.69 | -0.15% |
| 2025年12月31日 | $-1.00 | $-0.76 | -0.24% |
| 2025年9月30日 | $-0.95 | $-0.91 | -0.04% |
| 2025年6月30日 | $-0.95 | $-0.86 | -0.09% |
| 2025年3月31日 | $-0.88 | $-0.94 | 0.06% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Cost of Revenue | $21M | $4M | $2M | $3M | $3M | · | · | |
| R&D Expense | $452M | $506M | $456M | $399M | $451M | $337M | $210M | |
| SG&A Expense | $531M | $289M | $151M | $143M | $192M | $146M | $94M | |
| Operating Expenses | $1.03B | $815M | $617M | $590M | $646M | $483M | $307M | |
| Operating Income | $-523M | $-593M | $-607M | $-512M | $-577M | $-474M | $-266M | |
| Interest Expense | · | · | $81M | $80M | $47M | $37M | $9M | |
| Interest Income | $20M | $17M | $18M | $8M | $1M | $4M | $9M | |
| Other Non-op | $43M | $12M | $17M | $-8M | $36M | $2M | $-2M | |
| Pretax Income | $-733M | $-542M | $-653M | $-485M | · | $505M | $289M | |
| Income Tax | $435.0K | $1M | $0 | $0 | · | · | · | |
| Net Income | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| EPS (Basic) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| EPS (Diluted) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| Shares (Basic) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| Shares (Diluted) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| EBITDA | $-518M | $-587M | $-601M | $-505M | $-571M | $-474M | $-266M |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $570M | $681M | $376M | $377M | $394M | $356M | $364M | |
| Short-term Investments | · | $0 | $0 | $52M | $394M | $251M | $182M | |
| Receivables | $139M | $5M | $2M | · | · | · | · | |
| Inventory | $27M | $0 | · | · | · | · | · | |
| Prepaid Expense | $44M | $35M | $24M | $22M | $32M | $36M | $20M | |
| Current Assets | $798M | $721M | $478M | $549M | $889M | $643M | $569M | |
| PP&E (Net) | $5M | $7M | $12M | $15M | $30M | $20M | $6M | |
| Intangibles | $28M | $24M | $26M | $29M | $45M | $0 | · | |
| Other Non-current Assets | $17M | $18M | $23M | $20M | $33M | $24M | $26M | |
| Total Assets | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Accounts Payable | $36M | $10M | $11M | $12M | $12M | $9M | $9M | |
| Accrued Liabilities | · | · | · | · | · | · | $3M | |
| Current Liabilities | $288M | $154M | $144M | $121M | $135M | $96M | $60M | |
| Capital Leases | $4M | $5M | $9M | $12M | $17M | $15M | · | |
| Other Non-current Liabilities | $244.0K | $286.0K | $6M | $27M | $22M | $10M | $4M | |
| Total Liabilities | $3.01B | $2.38B | $1.89B | $1.87B | $1.88B | $596M | $156M | |
| Long-term Debt | $2.01B | · | · | · | · | $94M | $95M | |
| Total Debt | · | $437M | $446M | $431M | $431M | $94M | $92M | |
| Common Stock | $202.0K | $196.0K | $181.0K | $157.0K | $154.0K | $125.0K | $124.0K | |
| Paid-in Capital | $2.06B | $1.90B | · | · | · | · | · | |
| Retained Earnings | $-3.82B | $-3.10B | $-2.56B | $-1.92B | $-1.44B | $-889M | $-440M | |
| Treasury Stock | $323M | $275M | $275M | $275M | $275M | $75M | · | |
| AOCI | $12.0K | $8.0K | $31.0K | $-328.0K | $-132.0K | $192.0K | $254.0K | |
| Stockholders' Equity | $-2.09B | $-1.47B | $-1.35B | $-1.25B | $-870M | $58M | $408M | |
| Liabilities + Equity | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Shares Outstanding | 194,771,957 | 190,044,473 | 175,082,951 | 150,625,572 | 147,343,323 | 122,849,389 | 123,658,287 |
现金流 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $6M | $6M | $7M | $6M | $1M | $859.0K | |
| Stock-based Comp | $133M | $96M | $109M | $92M | $100M | $58M | $21M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Amort. of Intangibles | $3M | $2M | $2M | $2M | $3M | · | · | |
| Restructuring | · | $16M | $8M | $44M | $0 | $0 | · | |
| Other Non-cash | $149M | $-79M | $10M | $-33M | $-17M | · | · | |
| Operating Cash Flow | $-446M | $-521M | $-528M | $-419M | $-498M | $-400M | $-254M | |
| CapEx | $1M | $933.0K | $1M | $5M | $13M | $8M | $3M | |
| Investing Cash Flow | $-24M | $61M | $54M | $453M | $-201M | $-53M | $-217M | |
| Net Debt Issued | · | $-473M | $0 | $-20M | $-124M | · | · | |
| Stock Issued | $0 | $315M | $450M | $5M | $0 | $0 | · | |
| Stock Repurchased | $48M | $0 | $0 | $0 | $200M | $75M | · | |
| Net Stock Activity | $-48M | $315M | $144M | $5M | $-200M | $-75M | · | |
| Dividends Paid | · | · | · | · | · | · | $997.0K | |
| Financing Cash Flow | $359M | $748M | $452M | $-13M | $736M | $447M | $399M | |
| Net Change in Cash | $-111M | $289M | $-22M | $21M | $38M | $-6M | $-72M | |
| Taxes Paid | $1M | $0 | $0 | · | · | · | · | |
| Free Cash Flow | $-447M | $-522M | $-529M | $-424M | $-511M | $-407M | $-256M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% | -5752.0% | -656.4% | |
| Net Margin | -146.0% | -244.9% | -7021.9% | -624.2% | -841.2% | -6127.9% | -711.5% | |
| Pretax Margin | -145.9% | -244.3% | · | · | · | 6127.9% | 711.5% | |
| EBITDA Margin | -103.2% | -264.5% | -6458.9% | -650.9% | -818.7% | -5752.0% | -656.4% | |
| ROA | -79.0% | -74.1% | -111.7% | -59.2% | -68.3% | -75.7% | -52.6% | |
| ROE | 41.2% | 38.5% | 50.1% | 45.6% | 144.4% | -216.8% | -101.0% | |
| ROIC | 25.1% | 57.7% | · | · | · | · | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 | 6.7 | 9.4 | |
| Quick Ratio | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 | 6.3 | 9.0 | |
| Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| LT Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| Interest Coverage | · | · | -7.5 | -6.4 | -12.3 | -12.9 | -30.4 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.3 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | |
| Inventory Turnover | 1.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.0 | 68.6 | · | · | · | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 126.3% | 2285.3% | -88.0% | 11.4% | 745.1% | · | · | |
| Revenue CAGR 3Y | 86.3% | 47.1% | 4.1% | · | · | · | · | |
| Revenue CAGR 5Y | 127.4% | · | · | · | · | · | · |
估值 (TTM) 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Net Income TTM | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| Market Cap | $14.90B | $5.21B | $7.07B | $1.15B | $2.46B | $8.74B | $4.33B | |
| Enterprise Value | · | $4.97B | $7.14B | $1.15B | $2.10B | $8.22B | $3.88B | |
| P/E | -20.2 | -9.5 | -10.2 | -2.3 | -4.3 | -18.7 | · | |
| P/S | 29.7 | 23.5 | 759.8 | 14.8 | 35.3 | 1059.0 | 106.9 | |
| P/B | -7.1 | -3.6 | -5.2 | -0.9 | -2.8 | 150.9 | 10.6 | |
| P / Tangible Book | · | · | · | · | · | 150.9 | · | |
| P / Cash Flow | -33.4 | -10.0 | -13.4 | -2.7 | -4.9 | -21.9 | -17.1 | |
| P / FCF | -33.3 | -10.0 | -13.4 | -2.7 | -4.8 | -21.5 | -16.9 | |
| EV / EBITDA | · | -8.5 | -11.9 | -2.3 | -3.7 | -17.3 | -14.6 | |
| EV / FCF | · | -9.5 | -13.5 | -2.7 | -4.1 | -20.2 | -15.1 | |
| EV / Revenue | · | 22.4 | 767.3 | 14.8 | 30.1 | 996.8 | 95.7 | |
| Dividend Yield | · | · | · | · | · | · | 0.02% | |
| Earnings Yield | -4.9% | -10.5% | -9.8% | -42.8% | -23.4% | -5.3% | · | |
| Payout Ratio | · | · | · | · | · | · | -0.35% | |
| Annual Payout | · | · | · | · | · | · | $997.0K |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $195M | $154M | $121M | $111M | $117M | $6M | $3M | $2M | $211M | $2M | $4M | $2M | $2M | $2M | $338.0K | |
| Cost of Revenue | $15M | $10M | $8M | $7M | $4M | $3M | $2M | $598.0K | $598.0K | $598.0K | $598.0K | $598.0K | $599.0K | $651.0K | $647.0K | $739.0K | |
| R&D Expense | $149M | $127M | $116M | $113M | $111M | $111M | $130M | $120M | $115M | $141M | $130M | $125M | $107M | $93M | $91M | $93M | |
| SG&A Expense | $186M | $164M | $158M | $138M | $129M | $106M | $95M | $69M | $60M | $66M | $48M | $36M | $36M | $31M | $32M | $31M | |
| Operating Expenses | $351M | $300M | $294M | $266M | $245M | $221M | $232M | $194M | $178M | $211M | $179M | $162M | $148M | $128M | $131M | $129M | |
| Operating Income | $-107M | $-106M | $-140M | $-145M | $-134M | $-104M | $-226M | $-192M | $-176M | $343.0K | $-177M | $-158M | $-146M | $-126M | $-129M | $-129M | |
| Interest Expense | · | · | · | · | · | · | · | · | $23M | $23M | · | $20M | $21M | $20M | · | $20M | |
| Interest Income | $7M | $6M | $4M | $6M | $4M | $5M | $5M | $3M | $5M | $4M | $6M | $4M | $5M | $4M | $4M | $2M | |
| Other Non-op | $6M | $4M | $12M | $16M | $7M | $8M | $2M | $2M | $-632.0K | $9M | $22M | $-5M | $1M | $-601.0K | $5M | $6M | |
| Pretax Income | $-156M | · | $-195M | $-186M | $-182M | · | $-266M | $-164M | $-76M | · | · | · | · | · | · | · | |
| Income Tax | $0 | · | $-120.0K | $-2M | $2M | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-156M | $-167M | $-195M | $-185M | $-184M | $-170M | $-267M | $-164M | $-76M | $-36M | $-170M | $-179M | $-161M | $-143M | $-141M | $-140M | |
| EPS (Basic) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| EPS (Diluted) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| Shares (Basic) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| Shares (Diluted) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| EBITDA | $-107M | $-105M | · | $-145M | $-134M | $-103M | · | $-192M | $-176M | $2M | · | $-158M | $-146M | $-125M | · | $-129M |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $678M | $880M | $570M | $643M | $749M | $541M | $681M | $266M | $408M | $475M | $376M | $505M | $302M | $407M | $377M | $483M | |
| Short-term Investments | · | · | · | · | $8M | · | · | · | $40M | $44M | · | $0 | $31M | $34M | · | $75M | |
| Receivables | $254M | $205M | $139M | $117M | $77M | $115M | $5M | · | · | · | · | · | · | · | · | · | |
| Inventory | $53M | $33M | $27M | $25M | $18M | $4M | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $66M | $63M | $44M | $52M | $60M | $35M | $35M | $38M | $28M | $28M | · | $23M | $21M | $25M | · | $26M | |
| Current Assets | $1.09B | $1.24B | $798M | $839M | $912M | $695M | $721M | $445M | $616M | $783M | · | $588M | $433M | $553M | · | $642M | |
| PP&E (Net) | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $9M | $10M | $11M | · | $12M | $13M | $14M | · | $16M | |
| Intangibles | $27M | $27M | $28M | $29M | $30M | $28M | $24M | $25M | $25M | $26M | · | $27M | $28M | $28M | · | $29M | |
| Other Non-current Assets | $20M | $19M | $17M | $26M | $18M | $17M | $18M | $20M | $19M | $21M | · | $19M | $20M | $21M | · | $30M | |
| Total Assets | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Accounts Payable | $27M | $29M | $36M | $19M | $26M | $28M | $10M | $13M | $18M | $5M | · | $4M | $4M | $4M | · | $10M | |
| Current Liabilities | $891M | $816M | $288M | $217M | $176M | $152M | $154M | $139M | $134M | $141M | · | $106M | $110M | $97M | · | $119M | |
| Capital Leases | $15M | $14M | $4M | $3M | $4M | $5M | $5M | $6M | $7M | $8M | · | $10M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | $240.0K | $229.0K | $244.0K | $679.0K | $545.0K | $352.0K | $286.0K | $377.0K | $485.0K | $595.0K | · | $12M | $13M | $18M | · | $28M | |
| Total Liabilities | $3.72B | $3.64B | $3.01B | $2.92B | $2.86B | $2.52B | $2.38B | $1.88B | $1.88B | $1.89B | · | $1.85B | $1.85B | $1.84B | · | $1.86B | |
| Long-term Debt | $2.65B | $2.65B | $2.01B | $2.01B | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | $0 | · | $436M | $435M | $435M | · | $442M | $440M | $436M | · | · | |
| Common Stock | $206.0K | $204.0K | $202.0K | $200.0K | $198.0K | $197.0K | $196.0K | $195.0K | $194.0K | $193.0K | · | $180.0K | $168.0K | $167.0K | · | $156.0K | |
| Paid-in Capital | $2.16B | $2.11B | $2.06B | $2.02B | · | · | $1.90B | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-4.14B | $-3.99B | $-3.82B | $-3.63B | $-3.45B | $-3.26B | $-3.10B | $-2.83B | $-2.67B | $-2.60B | · | $-2.39B | $-2.22B | $-2.06B | · | $-1.78B | |
| Treasury Stock | $533M | $406M | $323M | $323M | $323M | $323M | $275M | $275M | $275M | $275M | · | $275M | $275M | $275M | · | $275M | |
| AOCI | $-7.0K | $-8.0K | $12.0K | $2.0K | $1.0K | $0 | $8.0K | $5.0K | $-4.0K | $2.0K | · | $34.0K | $63.0K | $-12.0K | · | $-348.0K | |
| Stockholders' Equity | $-2.52B | $-2.28B | $-2.09B | $-1.93B | $-1.79B | $-1.65B | $-1.47B | $-1.23B | $-1.09B | $-1.05B | · | $-1.21B | $-1.36B | $-1.23B | · | $-1.14B | |
| Liabilities + Equity | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Shares Outstanding | 195,284,352 | 195,707,702 | 194,771,957 | 192,633,286 | 191,162,659 | 189,826,023 | 190,044,473 | 188,986,547 | 188,032,738 | 187,122,744 | 175,082,951 | 174,131,954 | 161,419,931 | 160,435,238 | · | 149,367,087 |
现金流 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $44M | $33M | $35M | $35M | $37M | $26M | $30M | $27M | $21M | $17M | $37M | $23M | $27M | $22M | $22M | $17M | |
| Amort. of Intangibles | $700.0K | $700.0K | $700.0K | $700.0K | $700.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $300.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | $3M | $3M | · | $272.0K | $4M | $3M | $8M | $5M | |
| Other Non-cash | · | $-65M | · | · | · | $-57M | · | · | · | $-202M | · | · | · | $-25M | · | · | |
| Operating Cash Flow | $-71M | $-197M | $-56M | $-110M | $-81M | $-199M | $-195M | $-181M | $75M | $-220M | $-125M | $-145M | $-113M | $-144M | $-93M | $-135M | |
| CapEx | $443.0K | $69.0K | $33.0K | $470.0K | $594.0K | $0 | $47.0K | $137.0K | $54.0K | $695.0K | $435.0K | $431.0K | $428.0K | $12.0K | $801.0K | $759.0K | |
| Investing Cash Flow | $18M | $-43M | $-14M | $4M | $-13M | $-2M | $-3M | $38M | $3M | $23M | $-66.0K | $38M | $4M | $12M | $18M | $147M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $450M | · | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $-459M | · | · | · | $-23M | · | · | · | · | · | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $-18.0K | $-495.0K | $315M | $-454.0K | $306M | $1M | $143M | $5M | $0 | |
| Stock Repurchased | $128M | $82M | $0 | $0 | $0 | $48M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $-82M | · | · | · | $-48M | · | · | · | $315M | · | · | · | $143M | · | · | |
| Financing Cash Flow | $-149M | $550M | $-2M | $-894.0K | $302M | $60M | $474M | $707.0K | $-6M | $280M | $-5M | $307M | $-1M | $150M | $6M | $1M | |
| Net Change in Cash | $-202M | $310M | $-73M | $-106M | $208M | $-141M | $275M | $-142M | $72M | $83M | $-129M | $199M | $-110M | $18M | $-69M | $13M | |
| Free Cash Flow | · | $-197M | · | · | · | $-199M | · | · | · | $-220M | · | · | · | $-144M | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -43.9% | -54.5% | · | -120.3% | -121.4% | -89.5% | · | -7018.7% | -8096.8% | 0.16% | · | -3854.6% | -8903.1% | -6909.3% | · | -38200.0% | |
| Net Margin | -64.0% | -85.6% | · | -153.2% | -166.2% | -145.4% | · | -6012.2% | -3484.5% | -17.1% | · | -4387.4% | -9793.0% | -7816.6% | · | -41477.2% | |
| Pretax Margin | -64.0% | · | · | -154.5% | -164.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -43.9% | -53.9% | · | -120.3% | -121.4% | -88.4% | · | -7018.7% | -8096.8% | 0.92% | · | -3854.6% | -8903.1% | -6819.8% | · | -38200.0% | |
| ROA | -13.6% | -14.8% | · | -22.2% | -19.6% | -19.6% | · | -24.9% | -11.6% | -4.9% | · | -25.9% | -23.5% | -19.8% | · | -18.6% | |
| ROE | 7.2% | 8.5% | · | 11.7% | 12.8% | 12.6% | · | 13.5% | 6.2% | 3.2% | · | 15.3% | 13.5% | 12.6% | · | 14.9% | |
| ROIC | 4.3% | · | · | 7.4% | 7.6% | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.5 | · | 3.9 | 5.2 | 4.6 | · | 3.2 | 4.6 | 5.5 | · | 5.5 | 3.9 | 5.7 | · | 5.4 | |
| Quick Ratio | 1.0 | 1.3 | · | 3.5 | 4.7 | 4.3 | · | 1.9 | 3.3 | 3.7 | · | 4.8 | 3.0 | 4.6 | · | 4.7 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -7.7 | 0.0 | · | -7.8 | -7.1 | -6.3 | · | -6.5 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.5 | · | 0.5 | 0.4 | 1.3 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 1.2 | · | 2.1 | 2.8 | 2.0 | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $669M | $542M | · | $351M | $232M | $333M | · | $220M | $219M | $219M | · | $8M | $78M | $78M | · | $78M | |
| Net Income TTM | $-691M | $-705M | · | $-703M | $-593M | $-446M | · | $-455M | $-452M | $-519M | · | $-623M | $-446M | $-487M | · | $-505M | |
| Market Cap | $14.54B | $14.53B | · | $10.01B | $8.25B | $6.56B | · | $4.81B | $4.76B | $5.79B | · | $4.59B | $2.78B | $2.66B | · | $1.48B | |
| Enterprise Value | · | · | · | · | $7.50B | $6.02B | · | $4.98B | $4.75B | $5.70B | · | $4.53B | $2.88B | $2.65B | · | · | |
| P/E | -21.2 | -20.5 | · | -14.3 | -14.0 | -14.8 | · | -10.1 | -9.6 | -9.7 | · | -6.7 | -5.9 | -5.1 | · | -2.9 | |
| P/S | 21.7 | 26.8 | · | 28.5 | 35.6 | 19.7 | · | 21.9 | 21.7 | 26.5 | · | 581.5 | 35.8 | 34.3 | · | 19.0 | |
| P/B | -5.8 | -6.4 | · | -5.2 | -4.6 | -4.0 | · | -3.9 | -4.4 | -5.5 | · | -3.8 | -2.0 | -2.2 | · | -1.3 | |
| P / Cash Flow | · | -73.7 | · | · | · | -32.9 | · | · | · | -26.4 | · | · | · | -18.4 | · | · | |
| P / FCF | · | -73.6 | · | · | · | -32.9 | · | · | · | -26.3 | · | · | · | -18.4 | · | · | |
| EV / EBITDA | · | · | · | · | -55.8 | -58.4 | · | -26.0 | -27.1 | 2940.1 | · | -28.7 | -19.7 | -21.3 | · | · | |
| EV / FCF | · | · | · | · | · | -30.2 | · | · | · | -25.9 | · | · | · | -18.4 | · | · | |
| EV / Revenue | · | · | · | · | 32.3 | 18.1 | · | 22.6 | 21.7 | 26.1 | · | 573.5 | 37.2 | 34.2 | · | · | |
| Earnings Yield | -4.7% | -4.9% | · | -7.0% | -7.1% | -6.7% | · | -9.9% | -10.5% | -10.3% | · | -14.8% | -16.9% | -19.7% | · | -34.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $502M | $222M | $9M | $78M | $70M |
| 营业利润率 % | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% |
| 净收入 | $-733M | $-543M | $-653M | $-485M | $-586M |
| 稀释后每股收益 (EPS) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | -0.3 | -0.3 | -0.3 | -0.5 |
| 流动比率 | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 |
| 速动比率 | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-447M | $-522M | $-529M | $-424M | $-511M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 533 家申报者 · $11.5B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 99 (-2 与上一季度对比) | 65 (+8 与上一季度对比) | 176 (0 与上一季度对比) | 161 (+14 与上一季度对比) | +15.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $987677120 | 13260971 | 8.61% | 股份 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $800143332 | 10743063 | 6.97% | 股份 |
| VIKING GLOBAL INVESTORS LP | $741017831 | 9949219 | 6.46% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $588315509 | 7898973 | 5.13% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $570272655 | 7656722 | 4.97% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $360280689 | 4837281 | 3.14% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $351708339 | 4722185 | 3.06% | 股份 |
| Aisling Capital Management LP | $341834227 | 4589611 | 2.98% | 股份 |
| STATE STREET CORP | $330388215 | 4435932 | 2.88% | 股份 |
| UBS Group AG | $287753480 | 3863500 | 2.51% | 买入期权 |
| JANE STREET GROUP, LLC | $232407392 | 3120400 | 2.02% | 买入期权 |
| CITADEL ADVISORS LLC | $231388431 | 3106719 | 2.02% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $221507973 | 2973184 | 1.93% | 股份 |
| D. E. Shaw & Co., Inc. | $218406046 | 2932412 | 1.90% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195152496 | 2620200 | 1.70% | 买入期权 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $167728960 | 2252000 | 1.46% | 股份 |
| Polar Capital Holdings Plc | $153697598 | 2063609 | 1.34% | 股份 |
| FMR LLC | $152985495 | 2054048 | 1.33% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $145662994 | 1955733 | 1.27% | 股份 |
| SC US (TTGP), LTD. | $138559911 | 1860364 | 1.21% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127311718 | 1709341 | 1.11% | 股份 |
| NORGES BANK | $126152213 | 1693773 | 1.10% | 股份 |
| Frazier Life Sciences Management, L.P. | $115305393 | 1548139 | 1.00% | 股份 |
| Point72 Asset Management, L.P. | $113640243 | 1525782 | 0.99% | 股份 |
| JANE STREET GROUP, LLC | $112904828 | 1515908 | 0.98% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $107937207 | 1453504 | 0.94% | 股份 |
| Pictet Asset Management Holding SA | $107362071 | 1448126 | 0.94% | 股份 |
| TWO SIGMA ADVISERS, LP | $107165167 | 1401035 | 0.93% | 股份 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $102265291 | 1373057 | 0.89% | 股份 |
| Laurion Capital Management LP | $100714388 | 1352234 | 0.88% | 股份 |
| Hood River Capital Management LLC | $100364407 | 1347535 | 0.87% | 股份 |
| Balyasny Asset Management L.P. | $91614273 | 1230052 | 0.80% | 股份 |
| Squarepoint Ops LLC | $88760199 | 1191732 | 0.77% | 股份 |
| VANGUARD GROUP INC | $88444087 | 1156283 | 0.77% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $86057320 | 1155442 | 0.75% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $83193341 | 1116989 | 0.72% | 股份 |
| AMERIPRISE FINANCIAL INC | $82434273 | 1106795 | 0.72% | 股份 |
| PRIMECAP MANAGEMENT CO/CA/ | $75670190 | 1015980 | 0.66% | 股份 |
| FIL Ltd | $74648325 | 1002260 | 0.65% | 股份 |
| Clearbridge Investments, LLC | $73966324 | 993103 | 0.64% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $73400040 | 985500 | 0.64% | 卖出期权 |
| GOLDMAN SACHS GROUP INC | $66118056 | 887729 | 0.58% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $63817890 | 856846 | 0.56% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $61804000 | 829802 | 0.54% | 股份 |
| Ensign Peak Advisors, Inc | $56677567 | 760977 | 0.49% | 股份 |
| Qube Research & Technologies Ltd | $54162228 | 727205 | 0.47% | 股份 |
| Capital Research Global Investors | $52143969 | 700107 | 0.45% | 股份 |
| BARCLAYS PLC | $51071756 | 685711 | 0.44% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48652124 | 653224 | 0.42% | 股份 |
| First Turn Management, LLC | $47172951 | 633364 | 0.41% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $46288968 | 621494 | 0.40% | 股份 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $46261390 | 621125 | 0.40% | 股份 |
| BANK OF AMERICA CORP /DE/ | $41878465 | 562278 | 0.36% | 股份 |
| Cormorant Asset Management, LP | $40964000 | 550000 | 0.36% | 股份 |
| GILDER GAGNON HOWE & CO LLC | $40884008 | 548926 | 0.36% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $36316001 | 487594 | 0.32% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $35176457 | 472294 | 0.31% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $34092848 | 457745 | 0.30% | 股份 |
| Catalio Capital Management, LP | $33891454 | 455041 | 0.30% | 股份 |
| Bridgewater Associates, LP | $33377691 | 448143 | 0.29% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $32557442 | 437130 | 0.28% | 股份 |
| Fisher Asset Management, LLC | $25721741 | 345351 | 0.22% | 股份 |
| UBS Group AG | $25687705 | 344894 | 0.22% | 股份 |
| BOONE CAPITAL MANAGEMENT LLC | $25302346 | 339720 | 0.22% | 股份 |
| NOMURA HOLDINGS INC | $24390338 | 327475 | 0.21% | 股份 |
| Weiss Asset Management LP | $23847304 | 320184 | 0.21% | 股份 |
| Nicholas Investment Partners, LP | $23200073 | 311494 | 0.20% | 股份 |
| Woodline Partners LP | $22441718 | 301312 | 0.20% | 股份 |
| Candriam S.C.A. | $22361195 | 300520 | 0.19% | 股份 |
| MACKENZIE FINANCIAL CORP | $22227811 | 298440 | 0.19% | 股份 |
| Swiss National Bank | $21941808 | 294600 | 0.19% | 股份 |
| CITADEL ADVISORS LLC | $21278936 | 285700 | 0.19% | 买入期权 |
| CITADEL ADVISORS LLC | $20943776 | 281200 | 0.18% | 卖出期权 |
| Integral Health Asset Management, LLC | $20482000 | 275000 | 0.18% | 股份 |
| NOMURA HOLDINGS INC | $19811680 | 266000 | 0.17% | 买入期权 |
| PFM Health Sciences, LP | $18870104 | 253358 | 0.16% | 股份 |
| FIRST TRUST ADVISORS LP | $18451526 | 247738 | 0.16% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $18273370 | 245346 | 0.16% | 股份 |
| MARSHALL WACE, LLP | $17913781 | 240518 | 0.16% | 股份 |
| Caption Management, LLC | $17726240 | 238000 | 0.15% | 买入期权 |
| Susquehanna Portfolio Strategies, LLC | $16897203 | 226869 | 0.15% | 股份 |
| ExodusPoint Capital Management, LP | $16752563 | 224927 | 0.15% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $16565618 | 222417 | 0.14% | 股份 |
| NAN FUNG TRINITY (HK) LTD | $16327133 | 219215 | 0.14% | 股份 |
| ROYCE & ASSOCIATES LP | $16272912 | 218487 | 0.14% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $15553137 | 208823 | 0.14% | 股份 |
| ALGERT GLOBAL LLC | $15305417 | 205497 | 0.13% | 股份 |
| CITIGROUP INC | $14598080 | 196000 | 0.13% | 卖出期权 |
| California Public Employees Retirement System | $14514067 | 194872 | 0.13% | 股份 |
| Longaeva Partners L.P. | $13992036 | 187863 | 0.12% | 股份 |
| MIZUHO MARKETS AMERICAS LLC | $13585748 | 182408 | 0.12% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $13570256 | 182200 | 0.12% | 买入期权 |
| Cutter Capital Management, LP | $13504563 | 390644 | 0.12% | 股份 |
| ADAR1 Capital Management, LLC | $13159797 | 176689 | 0.11% | 股份 |
| BlackRock, Inc. | $12997803 | 174514 | 0.11% | 股份 |
| RHUMBLINE ADVISERS | $12750043 | 171188 | 0.11% | 股份 |
| ROYAL BANK OF CANADA | $12654000 | 169892 | 0.11% | 股份 |
| Hillsdale Investment Management Inc. | $12595462 | 169112 | 0.11% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12305105 | 165703 | 0.11% | 股份 |
| WCM INVESTMENT MANAGEMENT, LLC | $11891227 | 165133 | 0.10% | 股份 |
公司内部人士 25 位内幕人士 · 9 位高管 · 16 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Neil Kumar | Chief Executive Officer | 2026年8月16日 M | 278307 | 0 | 4 | $-1573882 |
| Thomas Trimarchi | President and CFO | 2026年8月16日 F | 336529 | 0 | 1 | $-2089887 |
| Brian C Stephenson | CFO and Treasurer | 2025年2月25日 M | 102464 | 0 | 0 | $0 |
| Brian M. Stolz | Chief Operating Officer | 2020年8月16日 M | 24615 | 0 | 0 | $0 |
| Maricel Apuli | Chief Accounting Officer | 2026年8月16日 F | 122687 | 0 | 1 | $-160120 |
| Cameron Turtle | Senior Vice President, Portfolio Management and Corporate Development | 2020年12月28日 M | 12568 | 0 | 0 | $0 |
| Michael Thomas Henderson | Chief Business Officer | 2020年12月15日 A | 274211 | 0 | 0 | $0 |
| Uma Sinha | Chief Scientific Officer | 2020年12月15日 A | 16460 | 0 | 0 | $0 |
| Yi Ching Yau | Chief Accounting Officer | 2020年11月16日 M | 4586 | 0 | 0 | $0 |
| Andrea Ellis | 董事 | 2026年7月9日 M | 22579 | 0 | 1 | $-1442028 |
| Jennifer E. Cook | 董事 | 2026年7月9日 M | 8383 | 0 | 6 | $-21920848 |
| Hannah Valantine | 董事 | 2026年6月22日 M | 9259 | 0 | 2 | $-341524 |
| Andrew Lo | 董事 | 2026年6月22日 A | 18079 | 0 | 0 | $0 |
| Douglas A. Dachille | 董事 | 2026年6月22日 A | 10579 | 0 | 0 | $0 |
| Ali J. Satvat | 董事 | 2026年6月22日 A | 169983 | 0 | 0 | $0 |
| Eric Aguiar | 董事 | 2026年6月22日 A | 10579 | 0 | 0 | $0 |
| Frank Mccormick | 董事 | 2026年6月22日 A | 10579 | 0 | 1 | $-3933840 |
| James C Momtazee | 董事 | 2026年6月22日 A | 19070 | 0 | 0 | $0 |
| Charles J Homcy | 董事 | 2026年6月22日 A | 919876 | 0 | 0 | $0 |
| DANIELS RONALD J | 董事 | 2026年6月22日 A | 20981 | 0 | 0 | $0 |
| Fred Hassan | 董事 | 2026年6月22日 A | 29879 | 0 | 0 | $0 |
| Randal W Scott | 董事 | 2025年6月20日 A | 11589 | 0 | 0 | $0 |
| Richard H Scheller | 董事 | 2023年2月16日 M | 53822 | 0 | 0 | $0 |
| Brent L Saunders | 董事 | 2022年6月22日 A | 17600 | 0 | 0 | $0 |
| BridgeBio Pharma, Inc. | 10% 所有者 | 2021年1月26日 P | 1000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| KKR Genetic Disorder L.P., KKR Genetic Disorder GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×8 申报 | 2026年8月17日 | 4.70% | 修订 | 资本结构 | SEC |
| VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Shabet Rose Sharon ×13 申报 | 2026年7月10日 | 5.00% | 修订 | — | SEC |
| BridgeBio Pharma, Inc. ×6 申报 | 2021年1月26日 | — | 初始申报 | 并购/出售 | SEC |
| Eidos Therapeutics, Inc. ×2 申报 | 2021年1月26日 | — | 初始申报 | — | SEC |
| BridgeBio Pharma LLC ×4 申报 | 2018年12月13日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 79 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 2.75% | 73191 NS | 2026年5月31日 | N-PORT |
| HRTS · Tema ETF Trust | 2.59% | 20327 NS | 2026年5月31日 | N-PORT |
| BBP · ETFis Series Trust I | 1.51% | 12592 NS | 2026年4月30日 | N-PORT |
| SPIT · RBB Fund, Inc. | 1.37% | 5527 NS | 2026年4月30日 | N-PORT |
| LFSC · RBB Fund, Inc. | 1.17% | 18534 NS | 2026年5月31日 | N-PORT |
| JSML · Janus Detroit Street Trust | 1.11% | 49222 NS | 2026年4月30日 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1.06% | 145924 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.93% | 68003 NS | 2026年4月30日 | N-PORT |
| ILDR · First Trust Exchange-Traded Fund ... | 0.82% | 35282 NS | 2026年5月31日 | N-PORT |
| GSC · Goldman Sachs ETF Trust | 0.73% | 27974 NS | 2026年5月31日 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0.73% | 2214 NS | 2026年5月31日 | N-PORT |
| BIB · ProShares Trust | 0.64% | 7167 NS | 2026年5月31日 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.62% | 3028 NS | 2026年5月31日 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0.60% | 188692 NS | 2026年6月30日 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0.58% | 69186 NS | 2026年4月30日 | N-PORT |
| FNY · First Trust Exchange-Traded Alpha... | 0.51% | 36933 NS | 2026年4月30日 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.49% | 20355 NS | 2026年5月31日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.41% | 18338 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.34% | 68833 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.26% | 7470 NS | 2026年5月31日 | N-PORT |
| FNX · First Trust Exchange-Traded Alpha... | 0.26% | 49007 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.24% | 815199 NS | 2026年5月31日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.23% | 20342 NS | 2026年4月30日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.23% | 77319 NS | 2026年4月30日 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0.21% | 68022 NS | 2026年4月30日 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.21% | 459045 NS | 2026年5月31日 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.20% | 56781 NS | 2026年4月30日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.19% | 28343 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.17% | 66688 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.16% | 5841 NS | 2026年5月31日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.15% | 10157 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.12% | 179 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.11% | 5909 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.06% | 6286 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.05% | 148 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.03% | 12546 NS | 2026年4月30日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.03% | 45958 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.02% | 6776 NS | 2026年4月30日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.02% | 883 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.02% | 30907 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.02% | 106480 NS | 2026年4月30日 | N-PORT |
| SCHK · SCHWAB STRATEGIC TRUST | 0.02% | 13777 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.02% | 99331 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 40764 NS | 2026年4月30日 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.01% | 2271 NS | 2026年5月31日 | N-PORT |
| GUSA · Goldman Sachs ETF Trust II | 0.01% | 4130 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |